Muge D. Orhan
Bahcesehir, 34353, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination.
Journal: ACS chemical neuroscience
Published: September 09, 2025
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study.
Journal: Molecular informatics
Published: August 25, 2021
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 21, 2021
Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing.
Journal: Structure (London, England : 1993)
Published: February 16, 2021
Hybrid In Silico and TR-FRET-Guided Discovery of Novel BCL-2 Inhibitors.
Journal: ACS pharmacology & translational science
Published: December 09, 2020
An Integrated in silico Approach and in vitro Study for the Discovery of Small-Molecule USP7 Inhibitors as Potential Cancer Therapies.
Journal: ChemMedChem
Published: August 28, 2020
Proposing novel MDM2 inhibitors: Combined physics-driven high-throughput virtual screening and in vitro studies.
Journal: Chemical biology & drug design
Published: February 22, 2020
Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2.
Journal: Frontiers in chemistry
Published: November 08, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026